x

Coronavirus

EU Doesn’t Renew Order for AstraZeneca Vaccine

PARIS — The EU Commission did not renew its order for AstraZeneca's COVID-19 vaccine, the European Union’s Internal Market Commissioner said Sunday.

“We have not renewed the order for after June. We’ll see what will happen next,” Thierry Breton told French radio France Inter.

The announcement comes one day after the European Union cemented its support for Pfizer-BioNTech's vaccine by agreeing to a massive contract extension for a potential 1.8 billion doses through 2023.

Two weeks ago, the EU launched legal proceedings against AstraZeneca for allegedly failing to respect the terms of its contract with the 27-nation bloc.

The AstraZeneca vaccine had been central to Europe’s immunization campaign and a linchpin in the global strategy to get vaccines to poorer countries since it is cheaper and easier to use than the Pfizer vaccine. But the slow pace of deliveries has frustrated the Europeans and they have held the company responsible for partly delaying their vaccine rollout.

Across the Channel, Britain has made the AstraZeneca vaccine the centerpiece of its successful vaccination campaign.

RELATED

BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.